Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Jul 23, 2018 · 10-Q · 23 days after period end · 0001144204-18-039198
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$3.09M | -$1.04M | -$962.00K | -$2.27M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Jul 23, 2018 · 23 d after period end
